Magnesium and Xermelo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Magnesium (magnesium) and Xermelo (telotristat etiprate). Common drug interactions include nausea among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Magnesium and Xermelo. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Magnesium?

Magnesium has active ingredients of magnesium. It is often used in constipation. eHealthMe is studying from 121,145 Magnesium users. Check the latest studies of Magnesium.

What is Xermelo?

Xermelo has active ingredients of telotristat etiprate. eHealthMe is studying from 2,149 Xermelo users. Check the latest studies of Xermelo.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 27, 2026

25 people who take Magnesium and Xermelo together, and have interactions are studied.

Magnesium and Xermelo drug interactions.

What are the common drug interactions of Magnesium and Xermelo, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Diarrhoea
  3. Decreased appetite
  4. Blood glucose decreased
  5. Blood pressure decreased
  6. Blood pressure increased
  7. Dizziness
  8. Dry mouth
  9. Fall
  10. Full blood count decreased

male:

  1. Diarrhoea
  2. Fatigue (feeling of tiredness)
  3. Muscle twitching
  4. Dry skin
  5. Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
  6. Neuropathy peripheral (surface nerve damage)
  7. Overgrowth bacterial (extra growth due to bacteria)
  8. Pain
  9. Peripheral swelling
  10. Pneumonia

What are the common drug interactions of Magnesium and Xermelo, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal pain
  2. Dyschezia (difficulty in defecating)
  3. Pain

50-59:

  1. Flushing (the warm, red condition of human skin)
  2. Diarrhoea
  3. Dry skin
  4. Fatigue (feeling of tiredness)
  5. Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
  6. Neuropathy peripheral (surface nerve damage)
  7. Overgrowth bacterial (extra growth due to bacteria)
  8. Pain
  9. Peripheral swelling
  10. Pneumonia

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Diarrhoea
  3. Full blood count decreased
  4. Glomerular filtration rate decreased
  5. Gout (uric acid crystals building up in the body)
  6. Oral pain
  7. Oropharyngeal pain
  8. Peripheral swelling
  9. Rash macular (small, flat red spots)
  10. Vomiting

What are the existing conditions these people have? *

  1. Carcinoid Syndrome (syndrome includes flushing and diarrhoea, and, less frequently, heart failure and bronchoconstriction): 15 people, 60.00%
  2. Neuroendocrine Tumor: 5 people, 20.00%
  3. Carcinoid Tumor Of The Small Bowel: 4 people, 16.00%
  4. Renal Cell Carcinoma (a kidney cancer): 3 people, 12.00%
  5. Tumor: 2 people, 8.00%
  6. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 8.00%
  7. Carcinoid Tumor: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Magnesium and Xermelo?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Magnesium and Xermelo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Magnesium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Xermelo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Magnesium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xermelo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on magnesium and telotristat etiprate (the active ingredients of Magnesium and Xermelo, respectively), and Magnesium and Xermelo (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: